Can-Fite Biopharma Ltd CANF-IL:Tel Aviv Stock Exchange

*Data is delayed | Exchange | ILS
Last | 05/09/24 EEST
2.70UNCH (UNCH)
52 week range
2.50 - 3.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.70
  • 52 Week High3.00
  • 52 Week High Date04/02/24
  • 52 Week Low2.50
  • 52 Week Low Date01/18/24

Key Stats

  • Market Cap10.49M
  • Shares Out1,497.13M
  • 10 Day Average Volume8.26M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.70
  • 52 Week High3.00
  • 52 Week High Date04/02/24
  • 52 Week Low2.50
  • 52 Week Low Date01/18/24
  • Market Cap10.49M
  • Shares Out1,497.13M
  • 10 Day Average Volume8.26M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Can-Fite Biopharma Ltd

 

Profile

MORE
Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is...
Ilan Cohen
Chairman of the Board
Pnina Fishman Ph.D.
Chief Executive Officer, Director
Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Address
26 Ben Gurion Street
Ramat Gan
5257346
Israel